Condition
Visual Perceptual Weakness
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed2
Enrolling By Invitation2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06368726Phase 1Enrolling By Invitation
Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders
NCT06044324Not ApplicableEnrolling By Invitation
Positron Emission Tomography in Transcranial Magnetic Stimulation Intervention for Treatment-resistant Depression
NCT06246318Not ApplicableCompleted
Effects of VR in Children With DCD: Randomized Controlled Trial
NCT05106166Not ApplicableCompleted
Joint Attention-Based Occupational Therapy Intervention in Pre-Schoolers With Autism Spectrum Disorder
Showing all 4 trials